The antifibrotic effects of plasminogen activation occur via prostaglandin E2 synthesis in humans and mice.
Saved in:
| Title: | The antifibrotic effects of plasminogen activation occur via prostaglandin E2 synthesis in humans and mice. |
|---|---|
| Authors: | Bauman KA; Department of Internal Medicine, Division of Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, Michigan, USA., Wettlaufer SH, Okunishi K, Vannella KM, Stoolman JS, Huang SK, Courey AJ, White ES, Hogaboam CM, Simon RH, Toews GB, Sisson TH, Moore BB, Peters-Golden M |
| Source: | The Journal of clinical investigation [J Clin Invest] 2010 Jun; Vol. 120 (6), pp. 1950-60. Date of Electronic Publication: 2010 May 24. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1558-8238 (Electronic) Linking ISSN: 00219738 NLM ISO Abbreviation: J Clin Invest Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 20501949 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: The antifibrotic effects of plasminogen activation occur via prostaglandin E2 synthesis in humans and mice. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Bauman+KA%22">Bauman KA</searchLink>; Department of Internal Medicine, Division of Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, Michigan, USA.<br /><searchLink fieldCode="AU" term="%22Wettlaufer+SH%22">Wettlaufer SH</searchLink><br /><searchLink fieldCode="AU" term="%22Okunishi+K%22">Okunishi K</searchLink><br /><searchLink fieldCode="AU" term="%22Vannella+KM%22">Vannella KM</searchLink><br /><searchLink fieldCode="AU" term="%22Stoolman+JS%22">Stoolman JS</searchLink><br /><searchLink fieldCode="AU" term="%22Huang+SK%22">Huang SK</searchLink><br /><searchLink fieldCode="AU" term="%22Courey+AJ%22">Courey AJ</searchLink><br /><searchLink fieldCode="AU" term="%22White+ES%22">White ES</searchLink><br /><searchLink fieldCode="AU" term="%22Hogaboam+CM%22">Hogaboam CM</searchLink><br /><searchLink fieldCode="AU" term="%22Simon+RH%22">Simon RH</searchLink><br /><searchLink fieldCode="AU" term="%22Toews+GB%22">Toews GB</searchLink><br /><searchLink fieldCode="AU" term="%22Sisson+TH%22">Sisson TH</searchLink><br /><searchLink fieldCode="AU" term="%22Moore+BB%22">Moore BB</searchLink><br /><searchLink fieldCode="AU" term="%22Peters-Golden+M%22">Peters-Golden M</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%227802877%22">The Journal of clinical investigation</searchLink> [J Clin Invest] 2010 Jun; Vol. 120 (6), pp. 1950-60. <i>Date of Electronic Publication: </i>2010 May 24. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+for+Clinical+Investigation%22">American Society for Clinical Investigation </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>7802877 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1558-8238 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200219738%22">00219738 </searchLink><i>NLM ISO Abbreviation: </i>J Clin Invest <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=20501949 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1172/JCI38369 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1950 Titles: – TitleFull: The antifibrotic effects of plasminogen activation occur via prostaglandin E2 synthesis in humans and mice. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Bauman KA – PersonEntity: Name: NameFull: Wettlaufer SH – PersonEntity: Name: NameFull: Okunishi K – PersonEntity: Name: NameFull: Vannella KM – PersonEntity: Name: NameFull: Stoolman JS – PersonEntity: Name: NameFull: Huang SK – PersonEntity: Name: NameFull: Courey AJ – PersonEntity: Name: NameFull: White ES – PersonEntity: Name: NameFull: Hogaboam CM – PersonEntity: Name: NameFull: Simon RH – PersonEntity: Name: NameFull: Toews GB – PersonEntity: Name: NameFull: Sisson TH – PersonEntity: Name: NameFull: Moore BB – PersonEntity: Name: NameFull: Peters-Golden M IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 06 Text: 2010 Jun Type: published Y: 2010 Identifiers: – Type: issn-electronic Value: 1558-8238 Numbering: – Type: volume Value: 120 – Type: issue Value: 6 Titles: – TitleFull: The Journal of clinical investigation Type: main |
| ResultId | 1 |